Westside Investment Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-100
Closed -$13 814
2022
Q2
$13 Hold
100
﹤0.01% 563
2022
Q1
$14 Hold
100
﹤0.01% 565
2021
Q4
$16 Hold
100
﹤0.01% 532
2021
Q3
$16 Hold
100
﹤0.01% 514
2021
Q2
$17 Hold
100
﹤0.01% 500
2021
Q1
$16 Hold
100
﹤0.01% 490
2020
Q4
$16 Hold
100
﹤0.01% 448
2020
Q3
$15 Hold
100
﹤0.01% 457
2020
Q2
$16 Hold
100
﹤0.01% 426
2020
Q1
$13 Buy
+100
New +$14.2K ﹤0.01% 433
2019
Q2
$14 Buy
+100
New +$13.8K ﹤0.01% 431
2018
Q4
$12.4K Buy
+100
New +$13.7K ﹤0.01% 430
2018
Q3
Sell
-100
Closed -$14.2K 749
2018
Q2
$14.2K Hold
100
0.01% 480
2018
Q1
$12.6K Hold
100
0.01% 498
2017
Q4
$12.6K Hold
100
0.01% 515
2017
Q3
$12.6K Hold
100
0.01% 494
2017
Q2
$11.3K Buy
+100
New +$10.8K 0.01% 506

Other funds holding FBT

Westside Investment Management's FBT Position: Q3 2022 in Review

Westside Investment Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2022, closing a stake of 100 shares — an estimated $13 sold.

Westside Investment Management first reported a position in FBT in Q2 2017 and held it in 17 quarters. The position peaked at $14.2K in Q2 2018. 218 funds tracked by Wall St. Rank hold FBT as of Q3 2022.

  • Westside Investment Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2022 after selling out during the quarter.
  • Westside Investment Management sold 100 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2022, an estimated $13.
  • Westside Investment Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2017 and held it in 17 quarters.
  • Westside Investment Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $14.2K in Q2 2018.
  • 218 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2022.

Based on Westside Investment Management's 13F filing for Q3 2022, filed 9 Nov 2022.